Publications found:
73,128
Sort by:
Trends and Innovations in Key Account Management
US$ 595.00
... , how can KAM meet the challenges that lie ahead? Trends and Innovations in Key Account Management provides anyone involved in developing, implementing or delivering ... for the implementation of a successful KAM programAbout FirstWord Reports FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and ...
July 2015
-
Global Healthcare Analytics Market Outlook (2014-2022)
US$ 4,150.00
... of skilled labor with analytical skills, patient data security and privacy issues are inhibiting the growth of the market. Global Healthcare Analytics Market is segmented based on products, applications, end users, components and geography. Based on the product type, the market is further segmented ...
July 2015
138 pages
Global Telemedicine Market Outlook (2015-2022)
US$ 4,150.00
The Global Telemedicine Market is estimated to be $16.5 billion in 2014 and is expected to reach $52.3 billion by 2022 growing at a CAGR of 15.51% from 2014 to 2022. The factors driving the Global Telemedicine Market include lack ... America and Europe lead Telemedicine Market because of high acceptance of technologies in these regions. Some of the key players in Telemedicine Market include Philips Healthcare, Siemens ...
July 2015
84 pages
Market Analysis of Overseas Medical Services Agency Industry in China 2015-2020 Proposal
US$ 3,500.00
... overseas medical treatment in China. By far, the demands for overseas medical services mainly focus on tumor treatment, cosmetology, high-end body check, etc. Due to high market ... report, AskCI will further disclose market potential and commercial opportunities for overseas medical services agency industry in China. Recommendations will be given at the end ...
June 2015
-
Physician Views: Evaluating the Launch of Novartis' Cosentyx for Psoriasis
US$ 695.00
Approved in both the US and EU at the beginning of the year, Novartis' first-to-market IL-17 inhibitor Cosentyx could be the most effective psoriasis treatment available, suggest key opinion leaders recently interviewed by FirstWord. Novartis certainly appears confident in the commercial outlook for Cosentyx ...
June 2015
-
2015-2019 French Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
... presents a comprehensive analysis of the French hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ... sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in French hospitals, including controls, calibrators and ...
June 2015
508 pages
2015-2019 German Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
... presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ... sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in German hospitals, including controls, calibrators and ...
June 2015
523 pages
2015-2019 Japanese Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,880.00
... presents a comprehensive analysis of the Japanese hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ... sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Japanese hospitals, including controls, calibrators and ...
June 2015
520 pages
2015-2019 Spanish Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
... presents a comprehensive analysis of the Spanish hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ... sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Spanish hospitals, including controls, calibrators and ...
June 2015
514 pages
2015-2019 UK Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 3,080.00
... presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ... sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in UK hospitals, including controls, calibrators and ...
June 2015
523 pages
2015-2019 US Hospital Clinical Chemistry and Immunodiagnostics Market
US$ 6,240.00
... presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ... sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in US hospitals, including controls, calibrators and ...
June 2015
543 pages
2015-2019 Italian Hospital Coagulation Testing Market
US$ 3,120.00
... , 28 tables, and presents a comprehensive analysis of the Italian hospital coagulation testing market, including: Major issues pertaining to the Italian coagulation laboratory practice, as well as key economic, regulatory ... five years. Volume and sales forecasts for 40 coagulation procedures performed in Italian hospitals, including typical coagulation daily work loads. Review of current instrumentation technologies ...
June 2015
394 pages
Future Horizons and Growth Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market 2015: Supplier Shares and Country Forecasts
US$ 10,000.00
... ). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging ... products suppliers develop more effective business, R&D and marketing strategies. Rationale The growing economic pressures on hospitals, coupled with ...
June 2015
973 pages
2015 Synthes: Organization, Technologies, Products, Marketing, R&D, Strategies
US$ 1,480.00
A strategic assessment of Synthers, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...
June 2015
30 pages
2015 J&J: Organization, Technologies, Products, Marketing, R&D, Strategies
US$ 1,480.00
A strategic assessment of J&J, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance ...
June 2015
46 pages
2015 New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape
US$ 10,000.00
... 2015 New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch’s new report, which provides comprehensive analysis of POC ... technologies and products, by test. Strategic Recommendations Specific opportunities for new POC instruments and reagent systems with potentially significant market ...
June 2015
973 pages
2015 New Frontiers in US Critical Care (ER, OR, ICU) Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape
US$ 10,000.00
... 2015 New Frontiers in US Critical Care (ER, OR, ICU) Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch’s new report, which provides comprehensive analysis of POC ... technologies and products, by test. Strategic Recommendations Specific opportunities for new POC instruments and reagent systems with potentially significant market ...
June 2015
973 pages
US Proton Therapy Market Outlook 2020
US$ 2,000.00
... number of proton therapy centers. Hence, many research institutions and hospitals have started investing in proton therapy to make it more accessible to patients. According to the “US Proton Therapy Market Outlook 2020”, report by RNCOS, the United States will be home to 29 such centers by 2020. Consequently, the market will ...
June 2015
75 pages
Charting MSL Activity and Performance
US$ 595.00
... in MS Excel. Charting MSL Activity and Performance distils the key findings from one of the most comprehensive surveys of specialist Medical Science Liaison (MSL) personnel in the ... and experiences of 80 MSLs, this survey identifies critical variations in MSL activity and presents thought-provoking ideas for the improvement of MSL performance and assessment and ...
June 2015
58 pages
Global Sports Medicine Market Outlook (2014-2022)
US$ 4,150.00
The Global Sports Medicine Market is accounted $31.5 billion in 2014 and is expected to reach $53.6 billion in 2022 at a Compound Annual Growth Rate of 6.8%. Sports medicine is about preventing and treating the ... likely to restraint the market growth. Insurance is posing challenge to sports medicine as it would not cover the sports injuries and reimbursement. The Global Sports Medicine Market is segmented by procedure type ...
June 2015
108 pages
Global Radiotherapy Market Outlook (2014-2022)
US$ 4,150.00
Global Radiotherapy Market is estimated to be $6.1 billion in 2014 with CAGR of 6.65% is expected to reach $10.2 billion by 2022. The global radiotherapy market is a widely growing sector in recent years and is driven by factors such as increasing number of cancer patients and untapped market in some ...
June 2015
117 pages
Idiopathic Pulmonary Fibrosis: KOL Insight
US$ 7,495.00
... for Idiopathic Pulmonary Fibrosis (IPF). Will either be able to establish themselves as first choice, and what future developments could unlock the market? Idiopathic Pulmonary Fibrosis: KOL Insight critically examines this therapeutic area through the expert insights of 12 leading US and European Key Opinion ...
May 2015
-
Physician Views: Assessing Competition in the Idiopathic Pulmonary Fibrosis Market
US$ 695.00
... been tracking developments in the IPF market via a number of previous Physician View polls, focusing on the respective clinical profiles of Esbriet and Ofev ... pulmonologists based in the US and EU5 markets to provide their initial assessment of these two breakthrough drugs for IPF. Specifically we are asking ...
May 2015
-
